• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.52% Nasdaq Down 0.25%

    AbbVie Inc. (ABBV)

    -NYSE
    69.73 Down 0.28(0.40%) 4:01PM EDT
    |After Hours : 69.73 0.00 (0.00%) 5:37PM EDT
    Add to Portfolio
    Prev Close:70.01
    Open:70.19
    Bid:69.79 x 500
    Ask:69.85 x 100
    1y Target Est:75.87
    Beta:1.56
    Earnings Date:Oct 29 - Nov 2 (Est.)
    Day's Range:69.28 - 70.79
    52wk Range:51.37 - 71.60
    Volume:9,872,039
    Avg Vol (3m):9,577,700
    Market Cap:111.09B
    P/E (ttm):54.22
    EPS (ttm):1.29
    Div & Yield:2.04 (3.00%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 0.40%111.09B
    MRKUp 0.15%166.83B
    NVSUp 0.59%252.05B
    PFEUp 0.25%222.60B

    Key Statistics

    Forward P/E (1 yr):13.86
    P/S (ttm):5.31
    Ex-Dividend Date:13-Jul-15

    Analysts

    Annual EPS Est (Dec-15) :4.26
    Quarterly EPS Est (Sep-15) :1.07
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.99

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback